Results 241 to 250 of about 3,220,825 (277)
Some of the next articles are maybe not open access.

Fibrinolytic agents inhibit platelet adhesion onto collagen type I-coated surfaces at high blood flow conditions.

Blood Coagulation and Fibrinolysis, 1998
The effect of fibrinolytic agents on platelet adhesion onto insolubilized collagen type I was evaluated. Normal human whole blood samples were incubated with agents and perfused over collagen-coated surfaces in a parallel-plate flow chamber.
T. C. Huang   +3 more
semanticscholar   +1 more source

Removal of Acute Coronary Thrombus With Fibrinolysin—In Vivo Experiment: A Preliminary Report on the Use of Fibrinolytic Agents in the Treatment of Acute Thrombosis

, 1961
THE USE of fibrinolytic agents in the treatment of acute coronary thrombosis seems to offer promising results. Various reports have been made that fibrinolysins have been used intravenously with encouraging results for the lysis of thrombi at numerous ...
H. E. Bolton   +4 more
semanticscholar   +1 more source

The use of fibrinolytic agents in the treatment of arterial occlusion

The American Journal of Surgery, 1962
Abstract The experience gained in the treatment of forty-three patients with acute arterial occlusions is reported. It is believed that on the basis of this experience that prompt local instillation of large amounts of fibrinolytic agents, plus embolectomy or endarterectomy when indicated, will lead to rapid resolution of the acute arterial ...
Eugene E. Cliffton, Robert L. Clarke
openaire   +3 more sources

Greater use of fibrinolytic agents urged

JAMA: The Journal of the American Medical Association, 1980
The thrombolytic agents urokinase and streptokinase are safe and more effective than traditional anticoagulants in treating deep-vein thrombosis and pulmonary embolism in carefully selected patients, a panel of experts convened by the National Institutes of Health (NIH) has concluded.
openaire   +2 more sources

Synthetic Fibrinolytic Agents Induction of Fibrinolytic Activity In Vitro

1978
Various asymmetric organic anions have been shown to possess the important capacity to enhance the endogenous fibrinolytic activity in human plasma in vitro. Their further development may well permit induction with them of the thrombolytic activity in human blood in vivo resulting in intravascular clot (thrombi, emboli) dissolution (thrombolysis) by ...
openaire   +2 more sources

Treatment of thrombophlebitis with a fibrinolytic agent

The American Journal of Cardiology, 1960
Abstract 1. 1. Fibrinolysin was administered to seventy-one patients in 218 separate intravenous infusions. Each infusion contained 50,000 to 100,000 Merck units dissolved in 100 to 250 ml. of 5 per cent glucose in water and was given over a half- to two-hour period. Side effects were limited to hyperpyrexia of 2 °F.
Nancy D. Davis   +2 more
openaire   +3 more sources

Treatment of Experimental Total Hyphemas With Intraocular Fibrinolytic Agents

Archives of Ophthalmology, 1962
Traumatic hyphema is always potentially dangerous. Total hyphema ("eight-ball hemorrhage") has an especially poor prognosis because it often results in glaucoma, iris atrophy, and hematogenous pigmentation of the cornea. The types of treatment advocated for traumatic hyphema include bed rest, sedatives, miotics, mydriatics, carbonic anhydrase ...
Abraham Pollen   +2 more
openaire   +4 more sources

Fibrinolytic agents: pharmacology, indications and prescribing

Nurse Prescribing, 2011
Fibrinolytic (thrombolytic) agents are used thrombolysis (clot breakdown) in several indications, including acute ST-elevation myocardial infarction, acute pulmonary embolism and acute ischaemic stroke. The pathophysiology of each condition is discussed, as well as indications for the use of fibrinolytic agents.
openaire   +2 more sources

Are We Using Fibrinolytic Agents Often Enough?

Annals of Internal Medicine, 1980
Excerpt The development and acceptance of new pharmacologic approaches to treatment are often painstakingly slow.
openaire   +3 more sources

The Fibrinolytic System and Thrombolytic Agents

2001
The formation of a haemostatic thrombus is a useful defence mechanism for the closure of vascular lesions. However, undesirable thrombi are also formed in closed vessels, e.g. over atherosclerotic plaques or after rupture of such plaques. It has long been assumed that the primary function of the fibrinolytic system consists of dissolving such thrombi ...
openaire   +2 more sources

Home - About - Disclaimer - Privacy